MetLife Investment Management’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $732K | Buy |
31,071
+4,664
| +18% | +$110K | ﹤0.01% | 1477 |
|
2025
Q1 | $634K | Sell |
26,407
-396
| -1% | -$9.51K | ﹤0.01% | 1598 |
|
2024
Q4 | $1.13M | Buy |
26,803
+4,025
| +18% | +$170K | 0.01% | 1348 |
|
2024
Q3 | $1.01M | Hold |
22,778
| – | – | 0.01% | 1384 |
|
2024
Q2 | $824K | Buy |
22,778
+2,125
| +10% | +$76.9K | ﹤0.01% | 1445 |
|
2024
Q1 | $891K | Buy |
20,653
+2,434
| +13% | +$105K | 0.01% | 1362 |
|
2023
Q4 | $280K | Hold |
18,219
| – | – | ﹤0.01% | 2045 |
|
2023
Q3 | $250K | Hold |
18,219
| – | – | ﹤0.01% | 2077 |
|
2023
Q2 | $292K | Buy |
18,219
+9,338
| +105% | +$150K | ﹤0.01% | 2031 |
|
2023
Q1 | $68.9K | Hold |
8,881
| – | – | ﹤0.01% | 2676 |
|
2022
Q4 | $172K | Hold |
8,881
| – | – | ﹤0.01% | 2343 |
|
2022
Q3 | $189K | Hold |
8,881
| – | – | ﹤0.01% | 2331 |
|
2022
Q2 | $121K | Hold |
8,881
| – | – | ﹤0.01% | 2632 |
|
2022
Q1 | $209K | Buy |
+8,881
| New | +$209K | ﹤0.01% | 2331 |
|